FDA approves new Novartis dual combination bronchodilator Utibron™ Neohaler® for patients with chronic obstructive pulmonary disease

FDA approves new Novartis dual combination bronchodilator Utibron™ Neohaler® for patients with chronic obstructive pulmonary disease

Oct 29, 2015
Source URL: https://qa1.novartis.us/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease-0

List of links present in page
  1. https://qa1.novartis.us/us-en/us-en/news/media-releases/fda-approves-new-novartis-dual-combination-bronchodilator-utibrontm-neohaler-patients-chronic-obstructive-pulmonary-disease-0